BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 16514428)

  • 1. Treatment of hepatitis C-virus-related glomerulonephritis.
    Kamar N; Rostaing L; Alric L
    Kidney Int; 2006 Feb; 69(3):436-9. PubMed ID: 16514428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
    Garini G; Allegri L; Vaglio A; Buzio C
    Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
    Ahmed MS; Wong CF; Shawki H; Kapoor N; Pandya BK
    Clin Nephrol; 2008 Apr; 69(4):298-301. PubMed ID: 18397706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hepatitis C-related kidney disease.
    Fabrizi F; Martin P; Cacoub P; Messa P; Donato FM
    Expert Opin Pharmacother; 2015; 16(12):1815-27. PubMed ID: 26161511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus associated glomerulopathies.
    Ozkok A; Yildiz A
    World J Gastroenterol; 2014 Jun; 20(24):7544-54. PubMed ID: 24976695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of HCV-associated cryoglobulinemic glomerulonephritis].
    Laurino S; Borrelli S; Catapano F; Mascia S; D'Angio' P; Calabria M; Grimaldi M; Salvio A; Minutolo R; De Nicola L; Conte G
    G Ital Nefrol; 2009; 26(3):318-27. PubMed ID: 19554529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapy.
    Morales JM; Kamar N; Rostaing L
    Contrib Nephrol; 2012; 176():10-23. PubMed ID: 22310777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis.
    Garini G; Allegri L; Carnevali L; Catellani W; Manganelli P; Buzio C
    Am J Kidney Dis; 2001 Dec; 38(6):E35. PubMed ID: 11728995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Difficulties in treatment of kidney diseases related to HCV infection].
    Jabłońska J; Kozłowska J
    Przegl Epidemiol; 2009; 63(1):75-8. PubMed ID: 19522231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.
    Alric L; Plaisier E; Thébault S; Péron JM; Rostaing L; Pourrat J; Ronco P; Piette JC; Cacoub P
    Am J Kidney Dis; 2004 Apr; 43(4):617-23. PubMed ID: 15042538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapies.
    Garini G; Allegri L; Lannuzzella F; Vaglio A; Buzio C
    Acta Biomed; 2007; 78(1):51-9. PubMed ID: 17687818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: case report and literature review.
    Francesca Donato M; Banfi G; Cresseri D; Battista Fogazzi G; Martin P; Messa P; Fabrizi F
    Int J Artif Organs; 2013 May; 36(5):367-72. PubMed ID: 23446762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of HCV-related cryoglobulinemic glomerulonephritis with double-filtration plasmapheresis and interferon combination therapy.
    Namba T; Shiba R; Yamamoto T; Hirai Y; Moriwaki T; Matsuda J; Kadoya H; Takeji M; Yamada Y; Yoshihara H; Yamauchi A
    Clin Exp Nephrol; 2010 Aug; 14(4):372-6. PubMed ID: 20467773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal manifestations of hepatitis C virus infection. Extrahepatic complications often are silent--and thus overlooked.
    Bandi L
    Postgrad Med; 2003 Feb; 113(2):73-6, 86. PubMed ID: 12611116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sofosbuvir and Daclatsvir in Treatment of Hepatitis C Virus-related Membranoproliferative Glomerulonephritis With Cryoglobulinemia in a Patient With Hepatitis C Genotype 4.
    Elmowafy AY; El Maghrabi HM; Zahab MA; Elwasif SM; Bakr MA
    Iran J Kidney Dis; 2018 Nov; 12(6):382-384. PubMed ID: 30595569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
    Ahmed MS; Wong CF
    J Nephrol; 2007; 20(3):350-6. PubMed ID: 17557269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed cryoglobulinaemia and hepatitis C virus infection.
    Grandinetti F; De Paola L; Prunesti P; Mazzitello G
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):579. PubMed ID: 9513839
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C virus-related heat-insoluble cryoglobulinemia and thrombotic microangiopathy.
    Wu H; Zou HB; Xu Y; Zhang L; Du YJ; Yu JY; Lu RH; Li X
    Am J Med Sci; 2013 Oct; 346(4):345-8. PubMed ID: 23744520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia.
    Muro K; Toda N; Yamamoto S; Yanagita M
    Intern Med; 2021 Feb; 60(4):583-589. PubMed ID: 32999232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD20 monoclonal antibody (rituximab) treatment for hepatitis C-negative therapy-resistant essential mixed cryoglobulinemia with renal and cardiac failure.
    Ghijsels E; Lerut E; Vanrenterghem Y; Kuypers D
    Am J Kidney Dis; 2004 May; 43(5):e34-8. PubMed ID: 15112197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.